These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 33390340

  • 1. Clinical Implications of Germline Testing in Newly Diagnosed Prostate Cancer.
    Loeb S, Giri VN.
    Eur Urol Oncol; 2021 Feb; 4(1):1-9. PubMed ID: 33390340
    [Abstract] [Full Text] [Related]

  • 2. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.
    Giri VN, Knudsen KE, Kelly WK, Cheng HH, Cooney KA, Cookson MS, Dahut W, Weissman S, Soule HR, Petrylak DP, Dicker AP, AlDubayan SH, Toland AE, Pritchard CC, Pettaway CA, Daly MB, Mohler JL, Parsons JK, Carroll PR, Pilarski R, Blanco A, Woodson A, Rahm A, Taplin ME, Polascik TJ, Helfand BT, Hyatt C, Morgans AK, Feng F, Mullane M, Powers J, Concepcion R, Lin DW, Wender R, Mark JR, Costello A, Burnett AL, Sartor O, Isaacs WB, Xu J, Weitzel J, Andriole GL, Beltran H, Briganti A, Byrne L, Calvaresi A, Chandrasekar T, Chen DYT, Den RB, Dobi A, Crawford ED, Eastham J, Eggener S, Freedman ML, Garnick M, Gomella PT, Handley N, Hurwitz MD, Izes J, Karnes RJ, Lallas C, Languino L, Loeb S, Lopez AM, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann M, Mille P, Miner MM, Morgan T, Moreno J, Mucci L, Myers RE, Nielsen SM, O'Neil B, Pinover W, Pinto P, Poage W, Raj GV, Rebbeck TR, Ryan C, Sandler H, Schiewer M, Scott EMD, Szymaniak B, Tester W, Trabulsi EJ, Vapiwala N, Yu EY, Zeigler-Johnson C, Gomella LG.
    J Clin Oncol; 2020 Aug 20; 38(24):2798-2811. PubMed ID: 32516092
    [Abstract] [Full Text] [Related]

  • 3. Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine.
    Marino F, Totaro A, Gandi C, Bientinesi R, Moretto S, Gavi F, Pierconti F, Iacovelli R, Bassi P, Sacco E.
    Prostate Cancer Prostatic Dis; 2023 Dec 20; 26(4):655-664. PubMed ID: 36434163
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men.
    Chandrasekar T, Gross L, Gomella LG, Hegarty SE, Leong JY, Giri VN.
    Eur Urol Oncol; 2020 Jun 20; 3(3):291-297. PubMed ID: 31278035
    [Abstract] [Full Text] [Related]

  • 5. Germline genetic testing for inherited prostate cancer in practice: Implications for genetic testing, precision therapy, and cascade testing.
    Giri VN, Hegarty SE, Hyatt C, O'Leary E, Garcia J, Knudsen KE, Kelly WK, Gomella LG.
    Prostate; 2019 Mar 20; 79(4):333-339. PubMed ID: 30450585
    [Abstract] [Full Text] [Related]

  • 6. Knowledge and practice regarding prostate cancer germline testing among urologists: Gaps to address for optimal implementation✰,✰✰.
    Loeb S, Byrne N, Walter D, Makarov DV, Wise DR, Becker D, Giri VN.
    Cancer Treat Res Commun; 2020 Mar 20; 25():100212. PubMed ID: 33091732
    [Abstract] [Full Text] [Related]

  • 7. Bringing Prostate Cancer Germline Genetics into Clinical Practice.
    Das S, Salami SS, Spratt DE, Kaffenberger SD, Jacobs MF, Morgan TM.
    J Urol; 2019 Aug 20; 202(2):223-230. PubMed ID: 30730411
    [Abstract] [Full Text] [Related]

  • 8. Germline Variant Spectrum Among African American Men Undergoing Prostate Cancer Germline Testing: Need for Equity in Genetic Testing.
    Giri VN, Hartman R, Pritzlaff M, Horton C, Keith SW.
    JCO Precis Oncol; 2022 May 20; 6(1):e2200234. PubMed ID: 35666082
    [Abstract] [Full Text] [Related]

  • 9. Disparities in germline testing among racial minorities with prostate cancer.
    Weise N, Shaya J, Javier-Desloges J, Cheng HH, Madlensky L, McKay RR.
    Prostate Cancer Prostatic Dis; 2022 Sep 20; 25(3):403-410. PubMed ID: 34775478
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines.
    Nicolosi P, Ledet E, Yang S, Michalski S, Freschi B, O'Leary E, Esplin ED, Nussbaum RL, Sartor O.
    JAMA Oncol; 2019 Apr 01; 5(4):523-528. PubMed ID: 30730552
    [Abstract] [Full Text] [Related]

  • 11. Practical Considerations and Challenges for Germline Genetic Testing in Patients With Prostate Cancer: Recommendations From the Germline Genetics Working Group of the PCCTC.
    Szymaniak BM, Facchini LA, Giri VN, Antonarakis ES, Beer TM, Carlo MI, Danila DC, Dhawan M, George D, Graff JN, Gupta S, Heath E, Higano CS, Liu G, Molina AM, Paller CJ, Patnaik A, Petrylak DP, Reichert Z, Rettig MB, Ryan CJ, Taplin ME, Vinson J, Whang YE, Morgans AK, Cheng HH, McKay RR.
    JCO Oncol Pract; 2020 Dec 01; 16(12):811-819. PubMed ID: 32986533
    [Abstract] [Full Text] [Related]

  • 12. Adaptation of the socioecological model to address disparities in engagement of Black men in prostate cancer genetic testing.
    Leader AE, Rebbeck TR, Oh WK, Patel AV, Winer EP, Bailey LO, Gomella LG, Lumpkins CY, Garraway IP, Aiello LB, Baskin ML, Cheng HH, Cooney KA, Ganzak A, George DJ, Halabi S, Hathaway F, Healy C, Kim JW, Leapman MS, Loeb S, Maxwell KN, McNair C, Morgan TM, Prindeville B, Soule HR, Steward WL, Suttiratana SC, Taplin ME, Yamoah K, Fortune T, Bennett K, Blanding-Godbolt J, Gross L, Giri VN.
    BMC Public Health; 2024 Sep 18; 24(1):2533. PubMed ID: 39289635
    [Abstract] [Full Text] [Related]

  • 13. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.
    Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH, Bekelman JE, Benson MC, Blanco A, Burnett A, Catalona WJ, Cooney KA, Cooperberg M, Crawford DE, Den RB, Dicker AP, Eggener S, Fleshner N, Freedman ML, Hamdy FC, Hoffman-Censits J, Hurwitz MD, Hyatt C, Isaacs WB, Kane CJ, Kantoff P, Karnes RJ, Karsh LI, Klein EA, Lin DW, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann MJ, Mark JR, McCue PA, Miner MM, Morgan T, Moul JW, Myers RE, Nielsen SM, Obeid E, Pavlovich CP, Peiper SC, Penson DF, Petrylak D, Pettaway CA, Pilarski R, Pinto PA, Poage W, Raj GV, Rebbeck TR, Robson ME, Rosenberg MT, Sandler H, Sartor O, Schaeffer E, Schwartz GF, Shahin MS, Shore ND, Shuch B, Soule HR, Tomlins SA, Trabulsi EJ, Uzzo R, Vander Griend DJ, Walsh PC, Weil CJ, Wender R, Gomella LG.
    J Clin Oncol; 2018 Feb 01; 36(4):414-424. PubMed ID: 29236593
    [Abstract] [Full Text] [Related]

  • 14. Helix: A Digital Tool to Address Provider Needs for Prostate Cancer Genetic Testing in Clinical Practice.
    Giri VN, Walker A, Gross L, Trabulsi EJ, Lallas CD, Kelly WK, Gomella LG, Fischer C, Loeb S.
    Clin Genitourin Cancer; 2022 Apr 01; 20(2):e104-e113. PubMed ID: 35012874
    [Abstract] [Full Text] [Related]

  • 15. Genetic Testing Guidelines and Education of Health Care Providers Involved in Prostate Cancer Care.
    Mark JR, McDougall C, Giri VN.
    Urol Clin North Am; 2021 Aug 01; 48(3):311-322. PubMed ID: 34210487
    [Abstract] [Full Text] [Related]

  • 16. Pretest Genetic Education Video Versus Genetic Counseling for Men Considering Prostate Cancer Germline Testing: A Patient-Choice Study to Address Urgent Practice Needs.
    Russo J, McDougall C, Bowler N, Shimada A, Gross L, Hyatt C, Kelly WK, Calvaresi A, Handley NR, Hirsch IH, Izes JK, Lallas CD, Mann M, Mark JR, Mille PJ, Preate D, Trabulsi EJ, Tsang M, Chandrasekar T, Weiner PR, Gomella LG, Giri VN.
    JCO Precis Oncol; 2021 Aug 01; 5():. PubMed ID: 34589662
    [Abstract] [Full Text] [Related]

  • 17. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
    Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, Fossati N, Gross T, Henry AM, Joniau S, Lam TB, Mason MD, Matveev VB, Moldovan PC, van den Bergh RCN, Van den Broeck T, van der Poel HG, van der Kwast TH, Rouvière O, Schoots IG, Wiegel T, Cornford P.
    Eur Urol; 2017 Apr 01; 71(4):618-629. PubMed ID: 27568654
    [Abstract] [Full Text] [Related]

  • 18. Germline genetic variants in men with prostate cancer and one or more additional cancers.
    Pilié PG, Johnson AM, Hanson KL, Dayno ME, Kapron AL, Stoffel EM, Cooney KA.
    Cancer; 2017 Oct 15; 123(20):3925-3932. PubMed ID: 28657667
    [Abstract] [Full Text] [Related]

  • 19. Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.
    Paller CJ, Antonarakis ES, Beer TM, Borno HT, Carlo MI, George DJ, Graff JN, Gupta S, Heath EI, Higano CS, McKay RR, Morgans AK, Patnaik A, Petrylak DP, Rettig MB, Ryan CJ, Taplin ME, Whang YE, Vinson J, Cheng HH, Giri VN, PCCTC Germline Genetics Working Group.
    Clin Genitourin Cancer; 2019 Aug 15; 17(4):275-282.e1. PubMed ID: 31171481
    [Abstract] [Full Text] [Related]

  • 20. Aligning germline and somatic mutations in prostate cancer. Are genetics changing practice?
    Cussenot O, Cancel-Tassin G, Rao SR, Woodcock DJ, Lamb AD, Mills IG, Hamdy FC.
    BJU Int; 2023 Nov 15; 132(5):472-484. PubMed ID: 37410655
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.